Literature DB >> 167721

The influence of environmental agents on prostaglandin biosynthesis and metabolism in the lung. Inhibition of lung 15-hydroxyprostaglandin dehydrogenase by exposure of guinea pigs to 100 per cent oxygen at atmospheric pressure.

D G Parkes, T E Eling.   

Abstract

Enzymes in the 100 000g supernatant fraction of guinea-pig lungs, in the presence of NAD-+, converted PGF-2 alpha (prostaglanding F-2 alpha) into a less-polar compound. The u.v. spectrum of this metabolite showed a strong absorption band at 230 nm, which is characteristic of a carbonyl group in conjugation with a double bond. Reduction of this metabolite with NaBH4 resulted in a compound that behaved like PGF2 ALPHA on t.l.c. and g.l.c. From this evidence we concluded that PGF2alpha is metabolized in vitro to 15-oxo-PGF2 alpha by the NAD-+-dependent prostaglandin dehydrogenase system of guinea-pig lung. The effect of exposure of the animal to SO-2 and O2 on the rate of prostaglanding biosynthesis and catabolism by lung fractions in vitro was studied. Exposure of guinea pigs to 500 p.m. of SO2 for 5h or to 50p.p.m for 9 days (6h/day) did not alter the production or degradation of prostaglandings by lung fractions in vitro. In contrast, exposure of guinea pigs to 100% O2 for 48 h inhibited the rate of prostaglanding metabolism in vitro by 60-70% without significantly altering the rate of biosynthesis by lung fractions. Inhibition of prostaglandin dehydrogenase activity in vitro by lung fractions after exposure of the animal to O2 was dependent on the duration of exposure. Gluthathione S-aryltransferase and catechol O-methyltransferase activites of guinea-pig lung 100 000g supernatant were unaltered by exposure of the animal to O2. Thus it appears that inhibition of pulmonary prostaglandin dehydrogenase by exposure of the animal to O2 is not the result of a general toxic response. It was postulated that the inhibition of prostaglanding dehydrogenase may occur after exposure of the animal to other oxidant gases.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167721      PMCID: PMC1165343          DOI: 10.1042/bj1460549

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  An enzyme from rat liver catalysing conjugations with glutathione.

Authors:  J Booth; E Boyland; P Sims
Journal:  Biochem J       Date:  1961-06       Impact factor: 3.857

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Prostaglandins and the lung.

Authors:  B L Fanburg
Journal:  Am Rev Respir Dis       Date:  1973-09

Review 4.  Prostaglandins.

Authors:  J W Hinman
Journal:  Annu Rev Biochem       Date:  1972       Impact factor: 23.643

5.  Prostaglandins.

Authors:  J E Pike
Journal:  Sci Am       Date:  1971-11       Impact factor: 2.142

6.  Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents.

Authors:  B B Vargaftig; N Dao
Journal:  Pharmacology       Date:  1971       Impact factor: 2.547

7.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

8.  The release of prostaglandins from lung and other tissues.

Authors:  P Piper; J Vane
Journal:  Ann N Y Acad Sci       Date:  1971-04-30       Impact factor: 5.691

Review 9.  Hypotheses on physiological roles of prostaglandins.

Authors:  E W Horton
Journal:  Physiol Rev       Date:  1969-01       Impact factor: 37.312

10.  Animal inhalation exposure chambers.

Authors:  R G Hinners; J K Burkart; C L Punte
Journal:  Arch Environ Health       Date:  1968-02
View more
  7 in total

1.  Studies on the biosynthesis, metabolism and transport of prostaglandins by the lung.

Authors:  T E Eling; M W Anderson
Journal:  Agents Actions       Date:  1976-07

2.  Effect of an acute exposure of guinea pigs to NO2 on pulmonary prostaglandin dehydrogenase and angiotensin converting enzyme.

Authors:  A Chaudhari; S Dutta
Journal:  Bull Environ Contam Toxicol       Date:  1980-11       Impact factor: 2.151

3.  Inhibition of pulmonary prostaglandin metabolism by exposure of animals to oxygen or nitrogen dioxide.

Authors:  A Chaudhari; K Sivarajah; R Warnock; T E Eling; M W Anderson
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

4.  Degradation of porstaglandin F2alpha in the human pulmonary circulation.

Authors:  P Jose; U Niederhauser; P J Piper; C Robinson; A P Smith
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

5.  Rapid reduction of prostaglandin 15-hydroxy dehydrogenase activity in rat tissues after treatment with protein synthesis inhibitors.

Authors:  G J Blackwell; R J Flower; J R Vane
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

6.  Modification by steroids of pulmonary oedema and prostaglandin E2 pharmacokinetics induced by endotoxin in rats.

Authors:  T Izumi; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

Review 7.  Pulmonary biosynthesis and metabolism of prostaglandins and related substances.

Authors:  T E Eling; A I Ally
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.